Carcinogenesis, Vol. 20, No. 3, 401-406,
March 1999
© 1999 Oxford University Press
Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells
Department of Pathology, 3055 Arlington Avenue, Medical College of Ohio, Toledo, OH 43699-0008 and
1 Marion Bessin Liver Research Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Gap junction proteins (connexins) are expressed in a cell-specific manner and expression is often reduced in neoplastic cells. We investigated the mechanisms of connexin32 (Cx32) and connexin43 (Cx43) expression in hepatic cells using MH1C1 rat hepatoma cells and freshly isolated, adult rat hepatocytes that express Cx32 but not Cx43 and WB-F344 rat liver epithelial cells that express Cx43 but not Cx32. Southern blotting after DNA restriction with MspI and HpaII indicated that two MspI/HpaII restriction sites in the Cx32 promoter (positions –147 and –847) were methylated in WB-F344 cells, but not in MH1C1 cells or hepatocytes. In contrast, an MspI/HpaII restriction site in the Cx43 promoter (position –38) was methylated in MH1C1 cells, but not in WB-F344 cells or hepatocytes. Transient transfection of the cell lines with connexin promoter–luciferase constructs indicated that the Cx32 promoter was 7-fold more active in MH1C1 cells and the Cx43 promoter was 5-fold more active in WB-F344 cells. These results suggest that transcription of Cx32 and Cx43 in hepatic cells is controlled by promoter methylation and by cell-specific transcription factors. Similar mechanisms may be involved in the reduced expression of these genes frequently observed in neoplastic cells.
Abbreviations: 5-AZA, 5-aza-2'-deoxycytidine; Cx26, connexin26; Cx32, connexin32; Cx43, connexin43; DEX, dexamethasone; FBS, fetal bovine serum; HBSS, Hank's balanced salt solution; SSC, saline/sodium citrate.
2 To whom correspondence should be addressed Email: rruch{at}mco.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. E.J Teunissen and M. F.A Bierhuizen Transcriptional control of myocardial connexins Cardiovasc Res, May 1, 2004; 62(2): 246 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. SAEZ, V. M. BERTHOUD, M. C. BRANES, A. D. MARTINEZ, and E. C. BEYER Plasma Membrane Channels Formed by Connexins: Their Regulation and Functions Physiol Rev, October 1, 2003; 83(4): 1359 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-T. Chen, Y.-W. Cheng, M.-C. Chou, T. Sen-Lin, W.-W. Lai, W. L. Ho, and H. Lee The Correlation between Aberrant Connexin 43 mRNA Expression Induced by Promoter Methylation and Nodal Micrometastasis in Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2003; 9(11): 4200 - 4204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Chipman, A. Mally, and G. O. Edwards Disruption of Gap Junctions in Toxicity and Carcinogenicity Toxicol. Sci., February 1, 2003; 71(2): 146 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mesnil and H. Yamasaki Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1 Cancer Res., August 1, 2000; 60(15): 3989 - 3999. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. J.King, L. H.Fukushima, T. A.Donlon, A.D. Hieber, K. A.Shimabukuro, and J. S.Bertram Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression Carcinogenesis, February 1, 2000; 21(2): 311 - 315. [Abstract] [Full Text] [PDF]
|
|